United States   Login  
North America
South America
Europe
Middle East / Africa
Asia / Pacific
Global Customer Support
×
×
Search
    ×

    COVID-19 vaccination preparedness

    Responsible. Responsive. Ready.

    BD has mobilized and our devices are set to deliver the COVID-19 vaccine to the world

    In the midst of this global pandemic, we understand the responsibility we carry as the world’s largest manufacturer of injection devices. This position of leadership is why we responded to the crisis early—rapidly scaling up our manufacturing operations. We took this initiative so that once the COVID-19 vaccine became available, BD syringes and needles would be ready. We are committed to enabling healthcare providers to deliver the best possible patient care, which includes meeting the critical need for vaccinations.

    View BD Statement on U.S. Needle and Syringe Availability »

    BD has committed more than

    1 billion injection devices

    to support COVID-19 vaccinations. Placed end to end, they would circle the Earth 2 times.

    From pellets to pallets to patients

    The journey of a vaccine delivery device

    Ordered

    BD is working with governments and organizations around the world to produce and supply injection devices for COVID-19 vaccination campaigns.

    As orders get placed, BD business and operations teams carefully plan new demand to not disrupt routine patient care.

    Produced

    Manufacturing and packaging of needles and syringes

    Plastic pellets called resin are heated, melted and injected into molds to create the syringe and plastic needle parts. Stainless steel strip is rolled into a tube, welded and shrunk to the proper wall thickness and gauge. This cannula is cut to length and put through a grinding process to form the sharp needle point. Separately, the parts for the needle and syringe are fed into high-speed assembly machines and then packaged.

    Inspected

    BD quality engineers review each step to ensure products are safe and meet strict specifications.

         

    Distributed

    Individual units are placed into case cartons, sterilized, stacked into pallets and loaded on trucks

    BD supply chain teams send these shipments to designated government or NGO distribution centers.

    Administered

    Partnering with healthcare workers on the front lines

    From here, they will be delivered to point-of-care sites and ultimately to healthcare workers who BD will help train to ensure safe delivery of COVID-19 vaccinations to patients.

     
    1. Ordered
    2. Produced
    3. Inspected
    4. Distributed
    5. Administered

    Ingeniux.Runtime.CMSAttribute Play

    Committed to enabling healthcare providers to deliver the best possible care. View our infographic to see how.

    View infographic

    Key goals

    Enabling the delivery of COVID-19 vaccinations:

    A legacy of patient care

    BD has been by the side of vaccine developers and healthcare providers for decades, ensuring the availability and safe administration of vaccines from polio to the seasonal flu.

    A mission of integrity

    BD is partnering with governments and NGOs to ensure we deliver the right type of injection device in the right quantities to the right place at the right time.

    A commitment to continuity

    BD has accelerated production of needles and syringes to ensure continuity of supply to our customers, while prioritizing patient care and meeting the requests for heightened vaccination needs.

    “We’re doubling down on what we do best—accessing our vast experience to help solve the healthcare community’s biggest challenges, working with urgency, as we innovate and ensure our front lines have the innovative solutions and tools they need to address this pandemic and enhance patient care, as they impact lives around the world.”

    Tom Polen
    Chief Executive Officer and President

    Nurse wearing gloves giving a woman an injection in the shoulder with a syringe with a BD Eclipse needle.

    Enabling global COVID-19 vaccination preparedness

    BD has already committed more than 1 billion injection devices to countries and nongovernmental organizations around the world*

    World map with the following countries highlighted; France, Belgium, Canada, U.S., U.K., Australia, Netherlands, Germany, Spain and Saudi Arabia showing the injection devices that have been committed to.

    * Publicly confirmed as of December 2020

    How BD is preparing for global COVID-19 vaccinations

    Play

    Show me

    Everything
    Everything Resources Blog Press Releases External Resources
    Blog

    How BD is preparing for global COVID-19 vaccination campaigns

    Blog

    Pellets to pallets to patients: delivering injection devices for COVID-19 vaccinations

    Press releases

    BD Surpasses 1 Billion Injection Device Orders in Support of COVID-19 Vaccination Efforts Around the World

    Press releases

    BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns

    BD resource

    Syringe and needle technology that makes a difference

    BD resource

    Our responsibility in a time of crisis

    BD resource

    BD Response Plan on COVID-19 (Coronavirus)

    BD resource

    BD COVID-19 response—supply continuity plan

    BD resource

    Scaling up your COVID-19 response: Options for optimising drug availability and safety

    BD resource

    Product training, education and clinical resources

    BD resource

    Increasing access to COVID-19 testing with our BD Veritor™ Plus System

    External resource

    Operation Warp Speed Vaccine Distribution Process Update

    External resource

    CDC: COVID-19 Vaccination Home

    External resource

    CDC: COVID-19 Vaccination Training Programs and Reference Materials

    External resource

    COVID-19 Vaccination Program interim playbook for Jurisdiction

    External resource

    Operation Warp Speed Vaccine Process

    External resource

    Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine

    BD resource

    Our responsibility in a time of crisis

    BD resource

    BD Response Plan on COVID-19 (Coronavirus)

    BD resource

    Syringe and needle technology that makes a difference

    BD resource

    BD COVID-19 response—supply continuity plan

    BD resource

    Scaling up your COVID-19 response: Options for optimising drug availability and safety

    BD resource

    Increasing access to COVID-19 testing with our BD Veritor™ Plus System

    BD resource

    Product training, education and clinical resources

    Blog

    How BD is preparing for global COVID-19 vaccination campaigns

    Blog

    Pellets to pallets to patients: delivering injection devices for COVID-19 vaccinations

    Press releases

    BD Surpasses 1 Billion Injection Device Orders in Support of COVID-19 Vaccination Efforts Around the World

    Press releases

    BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns

    External resource

    CDC: COVID-19 Vaccination Home

    External resource

    CDC: COVID-19 Vaccination Training Programs and Reference Materials

    External resource

    Operation Warp Speed Vaccine Distribution Process Update

    External resource

    COVID-19 Vaccination Program interim playbook for Jurisdiction

    External resource

    Operation Warp Speed Vaccine Process

    External resource

    Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine

    BD-22503 (12/20)

    Offerings
    Company
    Clinical Excellence
    Support